“Pharmacoeconomic Aspects of Warfarin and New Oral Anticoagulants Use As Prevention of Thromboembolic Complications in Patients With Atrial Fibrillation”. Ukrainian Journal of Cardiology, vol. 27, no. 4, Oct. 2020, pp. 45-53, https://doi.org/10.31928/1608-635X-2020.4.4553.